162 related articles for article (PubMed ID: 7619649)
1. [Pressor, renal and endocrine effects of systemic infusion of L-arginine in hypertensive patients].
Dell'Omo G; Catapano G; Ebel M; Gazzano A; Ducci M; Del Chicca M; Clerico A; Pedrinelli R
Ann Ital Med Int; 1995; 10(2):107-12. PubMed ID: 7619649
[TBL] [Abstract][Full Text] [Related]
2. Pressor, renal and endocrine effects of L-arginine in essential hypertensives.
Pedrinelli R; Ebel M; Catapano G; Dell'Omo G; Ducci M; Del Chicca M; Clerico A
Eur J Clin Pharmacol; 1995; 48(3-4):195-201. PubMed ID: 7589041
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension.
Weidmann P; Gnädinger MP; Ziswiler HR; Shaw S; Bachmann C; Rascher W; Uehlinger DE; Hasler L; Reubi FC
J Hypertens Suppl; 1986 Jun; 4(2):S71-83. PubMed ID: 2941546
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension.
Cusson JR; Thibault G; Kuchel O; Hamet P; Cantin M; Larochelle P
J Hum Hypertens; 1989 Apr; 3(2):89-96. PubMed ID: 2547952
[TBL] [Abstract][Full Text] [Related]
5. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
[TBL] [Abstract][Full Text] [Related]
6. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.
Tajiri K; Miyakawa H; Izumi N; Marumo F; Sato C
Hepatology; 1995 Nov; 22(5):1430-5. PubMed ID: 7590659
[TBL] [Abstract][Full Text] [Related]
7. Aging abolishes the renal response to L-arginine infusion in essential hypertension.
Campo C; Lahera V; Garcia-Robles R; Cachofeiro V; Alcazar JM; Andres A; Rodicio JL; Ruilope LM
Kidney Int Suppl; 1996 Jun; 55():S126-8. PubMed ID: 8743532
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
9. Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects.
Castejon AM; Hoffmann IS; Jimenez E; Cubeddu RJ; Baldonedo RM; Cubeddu LX
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S133-6. PubMed ID: 11986911
[TBL] [Abstract][Full Text] [Related]
10. The effect of oral contraceptives on the nitric oxide system and renal function.
Cherney DZ; Scholey JW; Cattran DC; Kang AK; Zimpelmann J; Kennedy C; Lai V; Burns KD; Miller JA
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1539-44. PubMed ID: 17715260
[TBL] [Abstract][Full Text] [Related]
11. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of L-arginine on insulin-mediated blood flow and glucose disposal in the elderly.
Meneilly GS; Battistini B; Floras JS
Metabolism; 2001 Feb; 50(2):194-9. PubMed ID: 11229429
[TBL] [Abstract][Full Text] [Related]
13. Renal and metabolic effects of L-arginine infusion in kidney transplant recipients.
Zhang XZ; Ghio L; Ardissino G; Tirelli AS; Daccò V; Testa S; Claris-Appiani A
Clin Nephrol; 1999 Jul; 52(1):37-43. PubMed ID: 10442494
[TBL] [Abstract][Full Text] [Related]
14. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
15. The humoral, renal and pressor effects of systemic L-arginine infusion in hypertensive patients.
Ebel M; Catapano G; Colombo MG; Clerico A; Giannessi D; del Chicca M; Lupetti S; Materazzi F; Pedrinelli R
J Hypertens Suppl; 1993 Dec; 11(5):S140-1. PubMed ID: 8158315
[No Abstract] [Full Text] [Related]
16. The vascular effects of L-Arginine in humans. The role of endogenous insulin.
Giugliano D; Marfella R; Verrazzo G; Acampora R; Coppola L; Cozzolino D; D'Onofrio F
J Clin Invest; 1997 Feb; 99(3):433-8. PubMed ID: 9022076
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
18. L-Arginine infusion increases glucose clearance during prolonged exercise in humans.
McConell GK; Huynh NN; Lee-Young RS; Canny BJ; Wadley GD
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E60-E66. PubMed ID: 16105862
[TBL] [Abstract][Full Text] [Related]
19. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
20. Impaired renal haemodynamic response to L-arginine in essential hypertension: role of buffering anion and tubuloglomerular feedback.
Biggi A; Carra N; Cabassi A; Barilli AL; Musiari L; Iori M; De Iaco G; Azzarone M; Novarini A; Montanari A
J Hypertens; 2007 Mar; 25(3):679-88. PubMed ID: 17278985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
